Principal Financial Group Inc Cyma Bay Therapeutics, Inc. Transaction History

Principal Financial Group Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$12.63 - $24.47 $34,391 - $66,631	2,723 Added 26.32%	13,068 $308,000
Q3 2023 Nov 02, 2023	SELL	$10.86 - $17.62 $13,401 - $21,743	-1,234 Reduced 10.66%	10,345 $154,000
Q2 2023 Aug 07, 2023	BUY	$7.47 - $10.95 $86,495 - $126,790	11,579 New	11,579 $126,000
Q4 2021 Feb 09, 2022	SELL	$3.23 - $4.6 $44,199 - $62,946	-13,684 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$3.47 - $4.42 $7,699 - $9,807	-2,219 Reduced 13.95%	13,684 $50,000
Q2 2021 Aug 10, 2021	BUY	$3.94 - $4.92 $2,371 - $2,961	602 Added 3.93%	15,903 $69,000
Q1 2021 May 10, 2021	BUY	$4.23 - $6.55 $4,555 - $7,054	1,077 Added 7.57%	15,301 $69,000
Q4 2020 Feb 08, 2021	BUY	$5.73 - $9.03 $81,503 - $128,442	14,224 New	14,224 $82,000
Q2 2020 Aug 05, 2020	SELL	$1.41 - $4.25 $29,167 - $87,915	-20,686 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$1.25 - $2.02 $13,322 - $21,529	10,658 Added 106.28%	20,686 $31,000
Q4 2019 Feb 05, 2020	BUY	$1.33 - $5.93 $13,337 - $59,466	10,028 New	10,028 $20,000
Q4 2018 Feb 14, 2019	SELL	$6.54 - $11.74 $204,545 - $367,180	-31,276 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$10.88 - $14.52 $6,234 - $8,319	573 Added 1.87%	31,276 $347,000
Q2 2018 Aug 13, 2018	BUY	$10.66 - $14.38 $327,293 - $441,509	30,703 New	30,703 $0

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.